Lab testing firm LabCorp (NYSE:LH) closed out its fiscal year on a down note, with profit growth below historical levels. However, its long-term track record remains intact, and the valuation is reasonable.

Investopedia Markets: Explore the best one-stop source for financial news, quotes and insights.

Full Year Recap
Revenues advanced 10.8% to $5.5 billion and consisted of a combination of organic growth and acquisitions. Organically, testing volumes increased 1.2% and higher pricing through revenue per requisition, which increased 4.2%. Management detailed that it is in the process of integrating its "Westcliff, Orchid Cellmark and Genzyme Genetics acquisitions."

Operating income fell 3.1% to $948.4 million as LabCorp took more than $160 million in amortization, restructuring and other special charges. Backing out these charges, management estimated that operating income actually improved by 4.8% to $1.1 billion. Net income fell 6.9% to $519.7 million as higher interest expenses ate into the bottom line. This worked out to $5.11 per diluted share. Again, backing out charges, management detailed that earnings advanced 6.5% to $6.37 per diluted share. Free cash flow fell 6.2% to $709.9 million, or approximately $7 per diluted share. (To know more about income statements, read Understanding The Income Statement.)

For the coming year, LabCorp expects revenue growth of 2 to 3.5%. Analysts currently project $5.6 billion in sales for 2012. The company projects $6.75 to $7.05 and free cash flow of around $800 million, or $7.85 per diluted share.

The Bottom Line
LabCorp's stock has recovered from the depths of last fall, when it declined to less than $75 per share. However, at $90 per share, the shares are still well below highs of more than $100 in mid-2011. At the current price, they trade at a reasonable forward P/E of 13, and even more reasonable forward free cash flow multiple of only about 11.2.

Despite having largely consolidated the market for independent lab testing firms, LabCorp appears able to continue growing profits at a double digit clip. Over the past five years it has been able to leverage annual sales growth of less than 9% into an annual earnings growth of more than 14%. This easily bests archrival Quest Diagnostics (NYSE:DGX), which has grown sales 6% and profits less than 9% over this same period.

Hospitals, including HCA Holdings (NYSE:HCA) and Health Management Associates (NYSY:HMA), still garner the lion's share of testing volumes throughout the country. Bio-Reference Labs (Nasdaq:BRLI), a lab tester in the eastern United States, has managed to grow sales and profits in excess of 20% and may offer a better combination of growth potential at a reasonable valuation, with a forward P/E of 12. But LabCorp is likely a safer bet given its geographic diversity and strong track record of managing its business for growth. (For additional reading, check out 5 Must-Have Metrics For Value Investors.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

At the time of writing, Ryan C. Fuhrmann did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Stock Analysis

    Allstate: How Being Boring Earns it Billions (ALL)

    A summary of what Allstate Insurance sells and whom it sells it to including recent mergers and acquisitions that have helped boost its bottom line.
  2. Options & Futures

    Cyclical Versus Non-Cyclical Stocks

    Investing during an economic downturn simply means changing your focus. Discover the benefits of defensive stocks.
  3. Investing Basics

    How to Deduct Your Stock Losses

    Held onto a stock for too long? Selling at a loss is never ideal, but it is possible to minimize the damage. Here's how.
  4. Economics

    Is Wall Street Living in Denial?

    Will remaining calm and staying long present significant risks to your investment health?
  5. Stock Analysis

    When Will Dick's Sporting Goods Bounce Back? (DKS)

    Is DKS a bargain here?
  6. Investing News

    How AT&T Evolved into a Mobile Phone Giant

    A third of Americans use an AT&T mobile phone. How did it evolve from a state-sponsored monopoly, though antitrust and a technological revolution?
  7. Stock Analysis

    Home Depot: Can its Shares Continue Climbing?

    Home Depot has outperformed the market by a wide margin in the last 12 months. Is this sustainable?
  8. Stock Analysis

    Yelp: Can it Regain its Losses in 2016? (YELP)

    Yelp investors have had reason to be happy recently. Will the good spirits last?
  9. Stock Analysis

    Is Walmart's Rally Sustainable? (WMT)

    Walmart is enjoying a short-term rally. Is it sustainable? Is Amazon still a better bet?
  10. Stock Analysis

    GoPro's Stock: Can it Fall Much Further? (GPRO)

    As a company that primarily sells discretionary products, GoPro and its potential falls right in line with consumer trends. Is that good or bad?
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>

You May Also Like

Trading Center